Sage Journals: Discover world-class research

Abstract

Background

Persistent inflammation plays a role in the pathogenesis of atherosclerosis. n-3 Fatty acids may have anti-inflammatory effects. This study examined the effect of plant-derived alpha-linolenic acid (ALA) and marine n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on high-sensitivity C-reactive protein (hsCRP), a systemic marker of (low-grade) inflammation.

Design/Methods

A supplementary study in the Alpha Omega Trial: a multicenter, double-blind, randomized, placebo-controlled trial of low-dose n-3 fatty acids. Patients were enrolled from 2002 to 2006 and followed for 40 months. A total of 2425 patients, aged 60–80 years (79% men), with a history of myocardial infarction, were randomly assigned to margarines supplemented with a targeted additional intake of 400 mg/day EPA and DHA, 2 g/day ALA, EPA-DHA plus ALA, or placebo for 40 months.

Results

Patients consumed on average 19.8 g margarine/day, providing an additional amount of 238 mg/day EPA with 158 mg/day DHA, 1.98 g/day ALA, or both, in the active treatment groups. In the placebo group, the geometric mean hsCRP (95% confidence interval (CI)) was 1.84 mg/l (95% CI: +1.70 to +2.00) at baseline and 1.98 mg/l (95% CI: 1.82 to 2.15) after 40 months (p < 0.0001). hsCRP levels were not affected by ALA (−5% versus placebo; 95% CI: −14% to +6%, p = 0.37), EPA-DHA (−8% versus placebo; 95% CI: −17% to +2%, p = 0.13), or EPA-DHA plus ALA (−3% versus placebo; 95% CI: −12% to +8%, p = 0.62).

Conclusions

Long-term supplementation with modest amounts of EPA-DHA, whether or not in combination with ALA, did not affect hsCRP levels in patients with a history of myocardial infarction.

Trial Registration ClinicalTrials.gov number

NCT00127452

Keywords

n-3 Fatty acids alpha-linolenic acid eicosapentaenoic acid docosahexaenoic acid high-sensitivity C-reactive protein randomized double-blind placebo-controlled trial

Get full access to this article

View all access options for this article.

References

Hansson

. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685–1695.

Perk

De Backer

Gohlke

. Authors/Task Force Members. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol 2012; 19: 585–667.

The emerging risk factors collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: An individual participant meta-analysis. Lancet 2010; 375: 132–140.

Abeywardena

Head

. Longchain n-3 polyunsaturated fatty acids and blood vessel function. Cardiovasc Res 2001; 52: 361–371.

Kromhout

Giltay

Geleijnse

. Alpha Omega Trial Group. n–3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010; 363: 2015–2026.

Reinders

Virtanen

Brouwer

. Association of serum n-3 polyunsaturated fatty acids with C-reactive protein in men. Eur J Clin Nutr 2012; 66: 736–741.

Einvik

Klemsdal

Sandvik

. A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Eur J Cardiovasc Prev Rehabil 2010; 17: 588–592.

Talukdar

Bae

. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010; 142: 687–698.

Markovic

O'Reilly

Fussell

. Role of single nucleotide polymorphisms of pro-inflammatory cytokine genes in the relationship between serum lipids and inflammatory parameters, and the lipid-lowering effect of fish oil in healthy males. Clin Nutr 2004; 23: 1084–1095.

10.

Kelley

Siegel

Fedor

. DHA Supplementation decreases C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 2009; 139: 495–501.

11.

Ciubotaru

Lee

Wander

. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J Nutr Biochem 2003; 14: 513–521.

12.

Sundrarjun

Komindr

Archararit

. Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis. J Int Med Res 2004; 32: 443–454.

13.

Tsitouras

Gucciardo

Salbe

. High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 2008; 40: 199–205.

14.

Zhao

Shao

Teng

. Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal Pro-brain Natriuretic Peptide in elderly patients with chronic heart failure. J Int Med Research 2009; 37: 1831–1841.

15.

Mori

Woodman

Burke

. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 2003; 35: 772–781.

16.

Madsen

Christensen

Blom

. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr 2003; 89: 517–522.

17.

Geelen

Brouwer

Schouten

. Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. Eur J Clin Nutr 2004; 58: 1440–1442.

18.

Madsen

Christensen

Schmidt

. C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: a placebo-controlled randomized study. Eur J Nutr 2007; 46: 428–430.

19.

Sanders

Gleason

Griffin

. Influence of an algal triacylglycerol containing docosahexaenoic acid (22: 6n-3) and docosapentaenoic acid (22: 5n-6) on cardiovascular risk factors in healthy men and women. Br J Nutr 2006; 95: 525–531.

20.

Murphy

Meyer

Mori

. Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors. Br J Nutr 2007; 97: 749–757.

21.

Malekshahi Moghadam

Saedisomeolia

Djalali

. Efficacy of omega-3 fatty acid supplementation on serum levels of tumour necrosis factor-alpha, C-reactive protein and interleukin-2 in type 2 diabetes mellitus patients. Singapore Med J 2012; 53: 615–619.

22.

Tayyebi-Khosroshahi

Houshyar

Dehgan-Hesari

. Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients. Saudi J Kidney Dis Transpl 2012; 23: 500–506.

23.

Eschen

Christensen

La Rovere

. Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure. Cell Mol Biol 2010; 56: 45–51.

24.

Trøseid

Arnesen

Hjerkinn

. Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men. Metabolism 2009; 58: 1543–1549.

25.

Geleijnse

Giltay

Schouten

. Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial. Am Heart J 2010; 159: 539–546.

26.

Giltay

Geleijnse

Schouten

. High stability of markers of cardiovascular risk in blood samples. Clin Chem 2003; 49: 652–655.

27.

de Mello

Schwab

Kolehmainen

. A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study. Diabetologia 2011; 54: 2755–2767.

28.

Wensley

Gao

Burgess

. C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC). Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 2011; 342: d548–d548.

29.

Kromhout

Yasuda

Geleijnse

. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? Eur Heart J 2012; 33: 436–443.

30.

Yang

Chen

. Effects of n-3 PUFA supplementation on plasma soluble adhesion molecules: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2012; 95: 972–980.

31.

Eussen

Geleijnse

Giltay

. Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction. Eur Heart J 2012; 33: 1582–1588.

32.

Levey

Stevens

Schmid

. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.14 MB

No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial

Abstract

Background

Design/Methods

Results

Conclusions

Trial Registration ClinicalTrials.gov number

Keywords

Get full access to this article

References

Supplementary Material